Changes in Adipokine, Resitin, and BDNF Concentrations in Treatment-Resistant Depression after Electroconvulsive Therapy
Objectives: One of the current challenges in psychiatry is the search for answers on how to effectively manage drug-resistant depression. The occurrence of drug resistance in patients is an indication for the use of electroconvulsive therapy (ECT). This method is highly effective and usually results...
Main Authors: | Agnieszka Permoda-Pachuta, Magda Malewska-Kasprzak, Maria Skibińska, Krzysztof Rzepski, Monika Dmitrzak-Węglarz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Brain Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3425/13/10/1358 |
Similar Items
-
Metabolic Syndrome and Adipokines Profile in Bipolar Depression
by: Karolina Bilska, et al.
Published: (2023-10-01) -
Electroconvulsive treatment of a patient with Parkinson’s disease and moderate depression
by: John Erik Berg
Published: (2011-02-01) -
Patients’, Carers’, and the Public’s Perspectives on Electroconvulsive Therapy
by: Chris Griffiths, et al.
Published: (2019-05-01) -
ELECTROCONVULSIVE THERAPY IN ELDERLY PERSONS WITH DEPRESSION: AN EXPERIENCE
by: Zeyne Alves Pires Scherer, et al.
Published: (2011-06-01) -
Intravenous Ketamine Therapy vs. Electroconvulsive Therapy in Depressive Cases
by: Gholam Reza Kheirabadi, et al.
Published: (2012-01-01)